Back to discover

Protein / target

Proliferation marker protein Ki-67

Encoded byMKI67P46013Homo sapiensSwiss-Prot
Degrader-tractable
Druggability
UniProt Ubiquitination
4
Research papers

Protein at a glance

Biological role

Molecular condensate scaffold

Strongest disease association

Alcohol drinking

Via encoding gene MKI67 · Genetic evidence · score 0.49

Research activity

Emerging research

4 papers · latest 2024

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Protein that associates with the surface of mitotic chromosomes and acts both as a chromosome repellent during early mitosis and chromosome attractant during late mitosis.

View complete UniProt function annotation

Protein that associates with the surface of mitotic chromosomes and acts both as a chromosome repellent during early mitosis and chromosome attractant during late mitosis (PubMed:27362226, PubMed:32879492, PubMed:35513709, PubMed:39153474). Required to maintain individual mitotic chromosomes dispersed in the cytoplasm following nuclear envelope disassembly (PubMed:27362226). During early mitosis, relocalizes from nucleoli to the chromosome surface where it forms extended brush structures that cover a substantial fraction of the chromosome surface (PubMed:27362226). The MKI67 brush structure prevents chromosomes from collapsing into a single chromatin mass by forming a steric and electrostatic charge barrier: the protein has a high net electrical charge and acts as a surfactant, dispersing chromosomes and enabling independent chromosome motility (PubMed:27362226). During mitotic anaphase, the MKI67 brush structure collapses and MKI67 switches from a chromosome repellent to a chromosome attractant to promote chromosome clustering and facilitate the exclusion of large cytoplasmic particles from the future nuclear space (PubMed:32879492, PubMed:39153474). Mechanistically, dephosphorylation during mitotic exit and simultaneous exposure of a conserved basic patch induce the RNA-dependent formation of a liquid-like condensed phase on the chromosome surface, promoting coalescence of neighboring chromosome surfaces and clustering of chromosomes (PubMed:39153474). Binds premature ribosomal RNAs during anaphase; promoting liquid-liquid phase separation (PubMed:28935370, PubMed:39153474). Binds DNA, with a preference for supercoiled DNA and AT-rich DNA (PubMed:10878551). Does not contribute to the internal structure of mitotic chromosomes (By similarity). May play a role in chromatin organization; it is however unclear whether it plays a direct role in chromatin organization or whether it is an indirect consequence of its function in mitotic chromosome (PubMed:24867636)

Subcellular location

ChromosomeNucleusNucleus, nucleolus
Domains and Gene Ontology detail (17)

Domains & features

FHAPP1-binding

Gene Ontology

  • Cchromosome
  • Ccondensed chromosome
  • Cmembrane
  • Cnucleolus
  • Cnucleoplasm
  • Cnucleus
  • FATP binding
  • FDNA binding
  • Fmolecular condensate scaffold activity
  • FRNA binding
  • Pcell population proliferation
  • Pchromosome segregation

3256 aa · 359 kDa · 2 isoforms

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Cell proliferation & survivalGO
View supporting evidence

Cell proliferation & survival

  • ·cell population proliferation

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene MKI67

Gene-level evidence surfaced through the gene MKI67that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Alcohol drinking
0.49Limited support

Genetic evidence dominant · Open Targets 0.30

Urolithiasis
0.49Limited support

Genetic evidence dominant · Open Targets 0.30

Intracranial Aneurysm
0.48Limited support

Genetic evidence dominant · Open Targets 0.29

Smoking initiation
0.45Limited support

Genetic evidence dominant · Open Targets 0.27

Intestinal Obstruction
0.40Limited support

Genetic evidence dominant · Open Targets 0.24

View evidence synthesis (5)
Alcohol drinkingLimited support
0.49
agreement 0.350.63
Genetic99%Literature1%

Open Targets aggregate 0.30 · 2 independent evidence families

UrolithiasisLimited support
0.49
agreement 0.370.61
Genetic100%

Open Targets aggregate 0.30 · 1 independent evidence family

Intracranial AneurysmLimited support
0.48
agreement 0.360.60
Genetic100%

Open Targets aggregate 0.29 · 1 independent evidence family

Smoking initiationLimited support
0.45
agreement 0.330.57
Genetic100%

Open Targets aggregate 0.27 · 1 independent evidence family

Intestinal ObstructionLimited support
0.40
agreement 0.260.54
Genetic99%Literature1%

Open Targets aggregate 0.24 · 2 independent evidence families

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Neurodegenerative Diseases0.37
Alcohol drinking0.30
Urolithiasis0.30
Intracranial Aneurysm0.29
Smoking initiation0.27
Intestinal Obstruction0.24
Drug Hypersensitivity0.24

Tractability

Protein degradersEmerging

Feasibility evidence (uniprot ubiquitination and database ubiquitination) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (2)
PR · UniProt UbiquitinationPR · Database Ubiquitination

Raw Open Targets tractability assessment buckets, by modality.

Research activity

4 papers · to 2024

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Recent

Europe PMC papers linked directly to this protein.